{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:01:38Z","timestamp":1784768498358,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04935-x","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:13:51Z","timestamp":1779858831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ACE inhibitor\u2013induced isolated intestinal angioedema mimicking functional bowel disorder: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Sai","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Nagda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarushi","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaily","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhi","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"6","key":"4935_CR1","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13\u2013115.","journal-title":"Hypertension"},{"issue":"33","key":"4935_CR2","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"14","key":"4935_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","volume":"165","author":"JB Kostis","year":"2005","unstructured":"Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(14):1637\u201342.","journal-title":"Arch Intern Med"},{"issue":"4","key":"4935_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","volume":"100","author":"A Banerji","year":"2008","unstructured":"Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitor\u2013induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100(4):327\u201332.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"4935_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.amjcard.2012.03.034","volume":"110","author":"H Makani","year":"2012","unstructured":"Makani H, Messerli FH, Romero J, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol. 2012;110(3):383\u201391.","journal-title":"Am J Cardiol"},{"issue":"7","key":"4935_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1524-6175.2004.02866.x","volume":"6","author":"DA Sica","year":"2004","unstructured":"Sica DA. Angiotensin-converting enzyme inhibitors side effects\u2014physiologic and non-physiologic considerations. J Clin Hypertens (Greenwich). 2004;6(7):410\u20136.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"20","key":"4935_CR7","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","volume":"172","author":"S Toh","year":"2012","unstructured":"Toh S, Reichman ME, Houstoun M, et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med. 2012;172(20):1582\u20139.","journal-title":"Arch Intern Med"},{"issue":"4","key":"4935_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.iac.2006.08.001","volume":"26","author":"JB Byrd","year":"2006","unstructured":"Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor\u2013associated angioedema. Immunol Allergy Clin North Am. 2006;26(4):725\u201337.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"6","key":"4935_CR9","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jemermed.2015.01.016","volume":"48","author":"AS Bloom","year":"2015","unstructured":"Bloom AS, Schranz C. Angiotensin-converting enzyme inhibitor\u2013induced angioedema of the small bowel\u2014a surgical-abdomen mimic. J Emerg Med. 2015;48(6):e127\u20139.","journal-title":"J Emerg Med"},{"issue":"2","key":"4935_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00000441-200208000-00011","volume":"324","author":"TD Schmidt","year":"2002","unstructured":"Schmidt TD, McGrath KM. Angiotensin-converting enzyme inhibitor angioedema of the intestine: a case report and review of the literature. Am J Med Sci. 2002;324(2):106\u20138.","journal-title":"Am J Med Sci"},{"issue":"5","key":"4935_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3949\/ccjm.78a.10102","volume":"78","author":"A Korniyenko","year":"2011","unstructured":"Korniyenko A, Alviar CL, Cordova JP, et al. Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy. Cleve Clin J Med. 2011;78(5):297\u2013304.","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"4935_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11739-016-1523-6","volume":"12","author":"M Beltrami","year":"2017","unstructured":"Beltrami M, Ruggieri S, Bani D, et al. Intestinal angioedema and ACE-inhibitors: evidence for involvement of the bradykinin pathway. Intern Emerg Med. 2017;12(4):547\u201350.","journal-title":"Intern Emerg Med"},{"issue":"8","key":"4935_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1398-9995.2007.01427.x","volume":"62","author":"M Bas","year":"2007","unstructured":"Bas M, Adams V, Suvorava T, et al. Nonallergic angioedema: role of bradykinin. Allergy. 2007;62(8):842\u201356.","journal-title":"Allergy"},{"issue":"3","key":"4935_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/jama.1997.03550030072037","volume":"278","author":"NJ Brown","year":"1997","unstructured":"Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor\u2013associated angioedema. JAMA. 1997;278(3):232\u20133.","journal-title":"JAMA"},{"issue":"12","key":"4935_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1155\/2001\/247816","volume":"15","author":"G Oudit","year":"2001","unstructured":"Oudit G, Girgrah N, Allard J. ACE inhibitor\u2013induced angioedema of the intestine: case report, incidence, pathophysiology, diagnosis and management. Can J Gastroenterol. 2001;15(12):827\u201332.","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"4935_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"4935_CR17","volume-title":"Uppsala Monitoring Centre. The use of the WHO\u2013UMC system for standardised case causality assessment","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Uppsala Monitoring Centre. The use of the WHO\u2013UMC system for standardised case causality assessment. Uppsala: WHO Collaborating Centre for International Drug Monitoring; 2013."},{"key":"4935_CR18","doi-asserted-by":"publisher","first-page":"bcr2013201554","DOI":"10.1136\/bcr-2013-201554","volume":"2013","author":"JJ Gagnier","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep. 2013;2013:bcr2013201554.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"4935_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.amjmed.2014.07.011","volume":"128","author":"S Bezalel","year":"2015","unstructured":"Bezalel S, Mahlab-Guri K, Asher I, et al. Angiotensin-converting enzyme inhibitor\u2013induced angioedema. Am J Med. 2015;128(2):120\u20135.","journal-title":"Am J Med"},{"issue":"5","key":"4935_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1056\/NEJMoa1312524","volume":"372","author":"M Bas","year":"2015","unstructured":"Bas M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor\u2013induced angioedema. N Engl J Med. 2015;372(5):418\u201325.","journal-title":"N Engl J Med"},{"issue":"5","key":"4935_CR21","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.jaip.2017.03.003","volume":"5","author":"R Sinert","year":"2017","unstructured":"Sinert R, Levy P, Bernstein JA, et al. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor\u2013induced upper airway angioedema. J Allergy Clin Immunol Pract. 2017;5(5):1402\u20139.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"4935_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1081-1206(10)60288-8","volume":"101","author":"BR Haymore","year":"2008","unstructured":"Haymore BR, Yoon J, Mikita CP, et al. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol. 2008;101(5):495\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"4935_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1345\/aph.1P630","volume":"45","author":"CJ Beavers","year":"2011","unstructured":"Beavers CJ, Dunn SP, Macaulay TE. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor\u2013induced angioedema. Ann Pharmacother. 2011;45(4):520\u20134.","journal-title":"Ann Pharmacother"},{"issue":"9117","key":"4935_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, et al. Plasma bradykinin in angioedema. Lancet. 1998;351(9117):1693\u20137.","journal-title":"Lancet"},{"issue":"4","key":"4935_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1086\/496899","volume":"77","author":"QL Duan","year":"2005","unstructured":"Duan QL, Nikpoor B, Dube MP, et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet. 2005;77(4):617\u201326.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"4935_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/FPC.0b013e328363c137","volume":"23","author":"G Pare","year":"2013","unstructured":"Pare G, Kubo M, Byrd JB, et al. Genetic variants associated with angiotensin-converting enzyme inhibitor\u2013associated angioedema. Pharmacogenet Genomics. 2013;23(9):470\u20138.","journal-title":"Pharmacogenet Genomics"},{"issue":"8","key":"4935_CR27","first-page":"2636","volume":"44","author":"A Matalon","year":"2019","unstructured":"Matalon A, Soffer S, Klang E, et al. CT findings of angiotensin-converting enzyme inhibitor\u2013induced small bowel angioedema: a systematic review. Abdom Radiol (NY). 2019;44(8):2636\u201343.","journal-title":"Abdom Radiol (NY)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04935-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:08:49Z","timestamp":1784765329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04935-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4935"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04935-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a single-patient retrospective case report. The patient was managed at S. Nijalingappa Medical College, Bagalkote, Karnataka. In accordance with the standing institutional policy of S. Nijalingappa Medical College, single-patient case reports of de-identified clinical material are exempt from formal ethical review and are not required to be submitted to the Institutional Ethics Committee; no written order, approval letter, or waiver reference number is issued by the Committee for such reports. Written informed consent to participate in the preparation of this report and to permit publication of de-identified case material was obtained from the patient, and the signed consent document is held by the corresponding author and can be supplied to the journal on request.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of this case report and any accompanying de-identified clinical details was obtained from the patient. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"469"}}